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Palatal fusion is a complex, multi-step developmental process; the consequence of failure in this process is cleft palate, one of the most
common birth defects in humans. Previous studies have shown that regression of the medial edge epithelium (MEE) upon palatal fusion is required
for this process, and TGF-β signaling plays an important role in regulating palatal fusion. However, the fate of the MEE and the mechanisms
underlying its disappearance are still unclear. By using the Cre/lox system, we are able to label the MEE genetically and to ablate Tgfbr2
specifically in the palatal epithelial cells. Our results indicate that epithelial–mesenchymal transformation does not occur in the regression of MEE
cells. Ablation of Tgfbr2 in the palatal epithelial cells causes soft palate cleft, submucosal cleft and failure of the primary palate to fuse with the
secondary palate. Whereas wild-type MEE cells disappear, the mutant MEE cells continue to proliferate and form cysts and epithelial bridges in
the midline of the palate. Our study provides for the first time an animal model for soft palate cleft and submucous cleft. At the molecular level,
Tgfb3 and Irf6 have similar expression patterns in the MEE. Mutations in IRF6 disrupt orofacial development and cause cleft palate in humans. We
show here that Irf6 expression is downregulated in the MEE of the Tgfbr2 mutant. As a recent study shows that heterozygous mutations in
TGFBR1 or TGFBR2 cause multiple human congenital malformations, including soft palate cleft, we propose that TGF-β mediated Irf6
expression plays an important, cell-autonomous role in regulating the fate of MEE cells during palatogenesis in both mice and humans.
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The mammalian palate develops from the primary palate
and the secondary palates (or palatal shelves). The primary
palate is derived from the frontonasal process, whereas the
secondary palates extend bilaterally from the internal surfaces
of the maxillary processes to form palatal shelves, which will
give rise to the hard palate in the anterior and the soft palate in
the posterior. Elevation and fusion of the palatal shelves are
two major events for palatogenesis. Perturbation of any step of
palatogenesis can cause cleft palate, one of the most frequent
congenital birth defects in the human population. The
incidence of cleft palate (without cleft lip) is about 1 in 500
live births (Tolarová and Cervenka, 1998). A large number of
the cleft palate cases involve the soft palate and submucous⁎ Corresponding author. Fax: +1 323 442 2981.
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doi:10.1016/j.ydbio.2006.05.014cleft (Heliövaara et al., 2005). By using mouse transgenic
models, many genes have been found to be involved in palate
development (Hilliard et al., 2005; Ito et al., 2003; Kaartinen
et al., 1995; Proetzel et al., 1995; Rice et al., 2004; Satokata
and Maas, 1994). However, most of these studies only
focused on hard palate development, and we still do not have
good animal models for soft palate cleft and submucous cleft
palate.
In the mouse embryo, palate shelves grow and elevate into a
horizontal position by postcoital day 14 (E14). The two palatal
shelves fuse in the midline and extend anteriorly to fuse with the
primary palate and nasal septum. The medial edge epithelia
(MEE) of the opposing palatal shelves form the midline
epithelial seam (MES), which eventually disappears following
palate fusion (Ferguson, 1988; Shuler, 1995; Wilkie and
Morriss-Kay, 2001). Numerous studies have explored the
mechanisms underlying the disappearance of MES, however,
there is still considerable disagreement regarding the fate of the
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support the theory that apoptosis is the major fate for the MES
(Cuervo and Covarrubias, 2004; Cuervo et al., 2002; DeAngelis
and Nalbandian, 1968; Mori et al., 1994; Shapiro and Sweney,
1969; Smiley and Dixon, 1968; Smiley and Koch, 1975). In
addition, part of the MEE migrates along the midline towards
the nasal and oral epithelia resulting in loss of MES (Carette and
Ferguson, 1992). A third theory suggests that the MES goes
through epithelial–mesenchymal transformation and transdif-
ferentiate into mesenchymal cells (Fitchett and Hay, 1989;
Griffith and Hay, 1992; Hay, 1995, 2005; Nawshad and Hay,
2003; Nawshad et al., 2004; Shuler et al., 1991, 1992).
Recently, however, this theory has been challenged by both in
vitro and in vivo studies (Cuervo et al., 2002; Vaziri Sani et al.,
2005).
Transforming growth factor β (TGF-β) signaling plays an
important role in regulating palatogenesis. TGF-β ligands
activate the membrane receptor serine/threonine kinase com-
plex composed of two type II (TGF-β IIR) receptors and two
type I (ALK5) receptors. The receptor complex phosphorylates
Smad2 and Smad3 to form transcriptional complexes with
Smad4; then the transcriptional complexes translocate into the
nucleus and control downstream target gene expression (Heldin
et al., 1997; Massague, 1998; Pelton et al., 1990). Both TGF-β1
and TGF-β3 are expressed in the MEE during mouse palate
development, whereas TGF-β2 is expressed in the mesenchyme
beneath the MEE (Fitzpatrick et al., 1990; Pelton et al., 1990).
In Tgfb2 null mutant mice, some of the newborns (23%) exhibit
cleft palate (Sanford et al., 1997). Tgfb3 null mutant mice show
complete phenotype penetrance of cleft palate (Kaartinen et al.,
1995; Proetzel et al., 1995). The failure of palatal shelf fusion in
Tgfb3 null mutant mice can be rescued by addition of
exogenous TGF-β3 in an in vitro organ culture system (Brunet
et al., 1995; Taya et al., 1999). Subsequent studies indicate that
TGF-β3 is required for the fusion of palatal shelves by inducing
programmed cell death in the MEE (Martinez-Alvarez et al.,
2000).
TGF-β IIR is expressed in both the MEE and the cranial
neural crest (CNC) derived palatal mesenchyme (Cui et al.,
1998; Wang et al., 1995). In our previous study, using a Tgfbr2
conditional gene ablation mouse model, we demonstrated that
TGF-β IIR plays a crucial, cell-autonomous role in regulating
the proliferation of CNC cells during palatogenesis (Ito et al.,
2003). However, the epithelium-specific role of TGF-β IIR was
not defined.
Taking advantage of the Cre/loxp recombination system,
we specifically labeled the MES and ablated the Tgfbr2 gene
in the epithelium component of palatal shelves. Our study
shows that epithelial–mesenchymal transformation does not
occur during palatogenesis; however, loss of Tgfbr2 in the
palatal epithelium impairs the disappearance of MEE and
results in soft palate cleft phenotype with complete phenotype
penetrance. Our study provides an important animal model
that mimics the human submucous cleft palate and fills a void
in cleft palate research. Studies using this animal model will
facilitate our understanding of the molecular regulatory
mechanisms of palatogenesis.Materials and methods
Two-component genetic system for marking the medial edge epithelial
cells
Male mice carrying the K14-Cre allele (Andl et al., 2004) were crossed with
females carrying the R26R conditional reporter allele (Soriano, 1999) to generate
K14-Cre;R26R embryos. Detection of β-galactosidase activity in tissue sections
was carried out as previously described (Chai et al., 2000).
Generation of K14-Cre;Tgfbr2fl/fl mutant mice, histological analysis
and scanning electron microscopy (SEM)
Male mice carrying the K14-Cre allele (Andl et al., 2004) were crossed
with Tgfbr2fl/fl females (Chytil et al., 2002) to generate the K14-Cre;Tgfbr2fl/+
mice. The male K14-Cre;Tgfbr2fl/+ mice were mated with Tgfbr2fl/fl female
mice to generate K14-Cre;Tgfbr2fl/fl null alleles that were genotyped using
PCR primers as previously described (Chytil et al., 2002). All samples were
fixed in 10% buffered formalin and processed into serial paraffin-embedded
sections using routine procedures. For general morphology, deparaffinized
sections were stained with hematoxylin and eosin using standard procedures.
For SEM, samples were fixed with 10% formalin at 4 °C for 12 h. After
dehydration through graded ethanol series, samples were critical point dried in
a Balzer Union (FL-9496) apparatus and coated with colloidal silver liquid
(Ted Pella Inc.) by using a Technics Hummer V sputter coater. Samples were
examined with a Cambridge 360 scanning electron microscope.
Apoptosis and cell proliferation
Following treatment with 20 mg/ml of proteinase K for 15 min at room
temperature, apoptotic cells were assayed by the TUNEL procedure using the In
Situ Cell Death Detection (fluorescein) kit (Roche Molecular Biochemicals)
following the manufacturer's protocol. Cell proliferation was scored by injection
of BrdU (5-bromo-2′-deoxy-uridine, Sigma. 100 μg/g body weight) into
pregnant females 1 h before recovery the embryos. Detection of BrdU-labeled
cells was carried out using a BrdU Labeling and Detection kit by following
manufacturer's protocol (Zymed).
Palatal shelf organ cultures
Timed-pregnant mice were sacrificed on postcoital day 13.5 (E13.5).
Genotyping was carried out as described above. The palatal shelves were
microdissected and cultured in serumless, chemically defined medium with
10 ng/ml BSA or 10 ng/ml TGF-β3 (R&D systems). Tissues were harvested
after 24 h of culture and fixed in 10% buffered formalin for processing.
Immunohistochemistry
The tissue was fixed with Carnoy's fixative solution (10% glacial acetic acid;
30% chloroform; 60% absolute ethyl alcohol, w/v) for immunohistochemistry.
Paraffin blocks containing processed mouse tissue were sectioned (5 μm in
thickness) for immunohistochemical analysis. The slides were heated in a 60°C
oven for 45min and subsequently hydrated towater through a series of decreasing
concentrations of ethanol. The immunohistochemical staining was performed by
using the Zymed HistoStain SP kit. The specific anti-phospho-Smad2 antibody
was generously provided by Dr. C.-H. Heldin (Ito et al., 2001; Xu et al., 2003).
In situ hybridization
In situ hybridizations were performed as previously described (Xu et al.,
2005). A 492-bp fragment of murineMmp13 cDNA subcloned into Pgem1 was
digested with HindIII and transcribed with T7 RNA polymerase (Boehringer
Mannheim) for the anti-sense probe. A 1600-bp fragment, derived from the 3′
untranslated region of murine Irf6 subcloned into pBKS was digested with
BamHI and transcribed with T3 RNA polymerase. The probe was labeled with
Digoxigenin.
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Fate of medial edge epithelium during palatogenesis
In order to provide a clear in vivo analysis of the dynamic
movement of MEE cells, we used the K14-Cre;R26R animal
model. The K14-Cre transgenic mice expressed CRE recombi-
nase in every cell of the palatal shelf epithelium before palatal
fusion started (Fig. 1A), and we were able to track the MEE
through the entire process of palatal fusion. At early E14,
secondary palatal shelves grew and elevated into a horizontal
position. The opposing palatal shelves covered by the MEE
contacted each other (Fig. 1B). At E14.5, MEE cells started to
disappear and to form the midline epithelial seam, which was
labeled by β-galactosidase staining (Fig. 1C). No β-galacto-
sidase-positive cells were found in the palatal mesenchyme
(Fig. 1C). At later developmental stages (E15.5, E16.5 and
E17.5), β-galactosidase-positive cells gradually disappeared
from the midline (Figs. 1D–F). Examination of serial sections of
the entire palate from K14-Cre;R26R embryos from E12.5 to
newborn did not reveal any β-galactosidase-positive cells in the
palatal mesenchyme following palatal fusion (Figs. 1A–F and
data not shown).
TGF-β IIR is specially required in the medial edge epithelium
during palatogenesis
Although the expression pattern of TGF-β IIR indicates that
it may play an important role in both MEE and palatal
mesenchyme during palatogenesis, mice deficient for Tgfbr2
gene die on embryonic day 10.5 (E10.5) as the result of defects
of yolk sac hematopoiesis and vasculogenesis (Oshima et al.,
1996). To bypass this early lethality and to investigate theFig. 1. β-Galactosidase staining of frontal sections from K14-Cre;R26R embryos.
epithelium cells are β-galactosidase positive. (B) At E14, the opposite secondary palat
galactosidase positive (insert). (C) At E14.5, the palatal shelves have fused, and
galactosidase positive cells can be found in the palatal mesenchyme. (D) At E15.5,
positive cells remain in the midline (arrow) and no β-galactosidase positive cells can
cells can be found in the palatal mesenchyme. P = Palatal shelf. T = Tongue.specific function of TGF-β signaling in regulating MEE cells
during palatogenesis, we crossed K14-Cre transgenic mouse
into a Tgfbr2 conditional allele (Tgfbr2fl/fl) background. These
mice (K14-Cre;Tgfbr2fl/+) were then crossed with Tgfbr2fl/fl
mice. At birth, we recovered K14-Cre;Tgfbr2fl/fl pups at the
expected Mendelian frequency of 25%. For those K14-Cre;
Tgfbr2fl/fl pups, the second exon of the Tgfbr2 gene was
removed in the Cre recombinase-positive cells, resulting in a
null allele as previously described (Chytil et al., 2002). The K14
promoter drove Cre recombinase expression specifically in the
ectodermal derived tissues, including the palatal epithelium
(Andl et al., 2004). In the control embryos, one or two active
Tgfbr2 alleles were retained.
The K14-Cre;Tgfbr2fl/flmutant newborn mice died soon after
birth and lacked milk in their stomachs (Fig. 2A). Macroscopic
examination showed severe defects of the palate: the primary
palate failed to fuse with secondary palatal shelves (Figs. 2C, D,
H), a shining transparent strip was located on the posterior part of
midline (Fig. 2E), and a complete cleft was found on the
posterior part of the soft palate (Fig. 2H). AllK14-Cre;Tgfbr2fl/fl
mutant newborn mice (n = 30) showed identical defects in the
palate.
By detailed histological analysis, several palatal fusion
defects were revealed. The primary palate failed to extend
backward and to fuse with the secondary palatal shelves.
Instead, the epithelium overgrew and formed an epithelial
tongue (Fig. 3B). The nasal septum also failed to fuse with the
palatal shelves (Fig. 3D). A persistent midline epithelial seam
was located in the anterior part of the secondary palate and
formed a cyst (Fig. 3F). In addition, an epithelial bridge
separated palatine bone and prevented fusion in the midline
(Fig. 3H). A complete cleft was manifested in the soft palate
(Figs. 3J, L, N). The transversal section showed that the(A) At E13.5, the secondary palate shelf projects toward the midline, palatal
e shelves contact each other, and the medial edge epithelial (MEE) cells are all β-
the midline epithelial seam (MES) is β-galactosidase positive (arrow), no β-
most of the MES (arrow) has disappeared. (E) At E16.5, few β-galactosidase
be found in the palatal mesenchyme. (F) At E17.5, no β-galactosidase positive
Fig. 2. Palatal defects in mice carrying epidermal-specific deletions of Tgfbr2 gene. (A) K14-Cre;Tgfbr2fl/fl (right) and control (left) newborns. (B) The palate has
completely fused and developed properly in the wild-type control. (C) K14-Cre;Tgfbr2fl/flmouse palate exhibits defects enlarged in panels (D) and (E). (D) In the K14-
Cre;Tgfbr2fl/fl sample, the primary palate fails to fuse with secondary palate (arrow) and (E) a transparent strip is located on the midline of the secondary palate (arrow).
(F–H) Scanning electron microcopy images of wild-type (F), Tgfβ3−/− (G), and K14-Cre;Tgfbr2fl/fl (H) palates show that the Tgfβ3−/− mouse exhibits complete cleft
palate, whereas the K14-Cre;Tgfbr2fl/flmouse only has cleft on the soft palate (double arrow) and on the junction of primary palate and secondary palate (arrow). (I, G)
BrdU staining shows that compared to the wild type (I) the Tgfβ3−/− mouse exhibits significantly reduced cell proliferation in the palatal mesenchyme at E14.5 (J).
Arrowheads point to the BrdU-positive cells.
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onto the posterior portion of the bony palate in the K14-Cre;
Tgfbr2fl/fl mutant, a typical malformation of the submucous
cleft (Figs. 3M, N).
TGF-β signaling and the fate of MEE
Apoptosis is the major fate for the MEE during palatal
fusion. To explore the mechanism responsible for the failure of
MEE disappearance in the Tgfbr2 mutant mice, we investi-
gated whether there was a decrease in apoptosis. In the wild-
type control sample at E14.5, apoptotic cells were found in the
medial edge seam at anterior, middle and posterior region of
the developing palate, particularly in the nasal and oral
epithelial triangles (Figs. 4A, E, I). In contrast, no apoptotic
positive cells were detected in the medial edge seam in the
anterior, middle and posterior region of palate in Tgfbr2 mutant
embryo, even though the secondary palate shelves had attached
to each other (Figs. 4B, F, J). The remaining medial edge
epithelial cells in the mutant palate still maintained the ability
to proliferate throughout the entire palate, as measured by
BrdU incorporation, while there was no proliferation activity in
the MEE of the wild-type sample (Figs. 4C, D, G, H, K, L).
Strikingly, elevated epithelial cell proliferation activity resulted
in the formation of an epithelial tongue, which prevented thefusion between primary and secondary palate in the Tgfbr2
mutant (Fig. 4D). In the middle and posterior part of the palate,
continued midline epithelial proliferation contributed to the
persistence of MEE and prevented palatal fusion in the mutant
sample (Figs. 4H, L).
BrdU incorporation analysis also indicated that there was no
defect of cell proliferation for the palatal mesenchyme in the
Tgfbr2 mutant mice (Figs. 4G, H, K, L). In contrast, Tgfb3 null
mutant mice exhibited a significant cell proliferation defect in
the palatal mesenchyme (Figs. 2I, J), causing a shortened palatal
shelf and complete cleft palate (Fig. 2G).
In order to investigate the functional significance of TGF-β
signaling in regulating apoptosis in the MEE, we added
recombinant TGF-β3 into a palatal organ culture. For the
wild-type samples, there was a significant increase in
apoptosis in the MEE 24 h after adding recombinant TGF-
β3 into the culture medium as compared with the untreated
control (Figs. 5A, B). In contrast, the MEE in the Tgfbr2
mutant sample did not respond to the TGF-β3 stimulation and
failed to show any sign of apoptosis (Fig. 5C). To test whether
this was due to a blocked TGF-β signaling pathway, we
examined the state of phospho-Smad2, an important intra-
cellular TGF-β signaling mediator, in the mutant MEE.
Phospho-Smad2 was expressed in the wild-type MEE but was
not detectable in the mutant MEE (Figs. 6A, B). Thus, loss of
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signaling and responsiveness.
Following the phosphorylation of receptor regulated Smad
(R-Smad, such as Smad2) by the TGF-β receptor, the R-Smad
forms a complex with common Smad, Smad4. This heteromeric
Smad complex then moves into the nucleus where it regulates
the transcription of target genes in conjunction with co-factors
as well as co-activators/co-repressors (Massague, 2000). Irf6
(interferon regulatory factor 6) is known to form a transcriptionFig. 3. Histological analyses of K14-Cre;Tgfbr2fl/flmutant palate. (A, C, E, G, I, K) Fr
Frontal sections of the K14-Cre;Tgfbr2fl/fl mutant palate, from anterior to posterior. (B
form an epithelial tongue (arrow). (D) The nasal septum fails to fuse with the second
palate (arrow and insert). (H) An epithelial bridge connects the hard palate (arrow). (J
the posterior of the soft palate, there is a complete cleft. (M) Transversal section of the
(insert). (N) Transversal section of the K14-Cre;Tgfbr2fl/fl mutant palate. The musc
(insert).regulatory complex with Smad to regulate downstream target
gene expression (Eroshkin and Mushegian, 1999). Interestingly,
haploinsufficiency of IRF6 results in cleft lip and palate in
humans (Kondo et al., 2002). More recently, studies have
shown that Irf6 is expressed in the MEE during palatal fusion
(Knight et al., 2006). Therefore, we examined the expression of
Irf6 in the Tgfbr2 mutant sample. Significantly, Irf6 expression
was sharply downregulated in the MEE of the Tgfbr2 mutant
palate as compared to that of the wild type (Figs. 7A, B),ontal sections of the wild-type palate, from anterior to posterior. (B, D, F, H, J, L)
) In the K14-Cre;Tgfbr2fl/fl sample, the primary palate epithelium overgrows to
ary palatal shelves (arrow). (F) An epithelial cyst is located in the midline of the
) The epithelial bridge is elongated on the more posterior region (arrow). (L) On
wild-type palate. The direction of muscle fiber is marked by a white dashed line
le attachments of the soft palate are directed anteriorly instead of horizontally
Fig. 4. The fate of the MEE is changed in the K14-Cre;Tgfbr2fl/fl mutant palate. (A, E, I) At E14.5, wild-type MEE cells show positive TUNEL staining, a marker for
cell death (arrow) from anterior to posterior part of the palate. (B, F, J) No cell death can be detected in the K14-Cre;Tgfbr2fl/flmutant palate. (C, G, K) At E15.5, palatal
fusion process has reached the end, most of the wild-type MEE cells have disappeared. (D, H, L) At E15.5, the K14-Cre;Tgfbr2fl/fl mutant MEE cells are still
maintained the ability to proliferate and are positive for BrdU staining (arrow) throughout the entire palate. Red dash lines label the boundary of the palatal epithelium
and mesenchyme.
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the disappearance of MEE during palatal fusion.
Finally, matrix remodeling is critical for successful palatal
shelf elevation, medial edge epithelium breakdown, and
mesenchyme flow after palatal fusion (Brown et al., 2002).
We investigated the expression ofMmp13 during the process of
palatal fusion in wild-type and mutant samples. Mmp13 was
expressed in the MEE and was induced by the contact and
adherence of the opposite palatal shelves in wild type (Fig. 7C).
In contrast, Mmp13 was not detectable in the Tgfbr2 mutant
MEE (Fig. 7D), suggesting that downregulation ofMmp13 mayFig. 5. Tgfbr2fl/fl mutant palatal epithelium fails to display TGF-β3-induced apoptosi
wild type treated with TGF-β3 (B), K14-Cre;Tgfbr2fl/fl treated with TGF-β3 (C). Ainterfere with apoptosis in the MEE and may contribute to the
cleft palate phenotype.
Discussion
Disappearance of the medial edge epithelium is a key event
during palatal development. However, the mechanisms under-
lying this phenomenon are still unknown. In this study, we
investigated the molecular mechanism by which the Tgfbr2
gene regulates the fate of MEE cells. By using a K14-Cre
transgenic allele, which exhibits robust and specific CREs. TUNEL assays of E13.5 palatal shelves from wild type treated with BSA (A),
rrows point to apoptotic cells.
Fig. 6. Blocked TGF-β signaling pathway in the Tgfbr2fl/flmutant MEE. (A) Wild-type MEE at E14.5 shows positive anti-Phospho-Smad2 signals (insert, arrowhead).
(B) In the K14-Cre;Tgfbr2fl/fl mutant sample, no Phospho-Smad2 is detected in the MEE.
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gene from the developing palate days before the palatal fusion
started in order to address the functional significance of TGF-β
signaling in regulating palatogenesis. Our results indicate that
TGF-β signaling is crucial for the normal process of palatal
fusion. Specifically, loss of Tgfbr2 in the palatal epithelium
results in the failure of disappearance of MEE. In these mice, the
fate of the MEE was changed, programmed cell death was
interrupted and proliferation ability was restored. This immortal
MEE prevents the normal fusion of the palatal shelves, causingFig. 7. Irf6 and MMP13 are downregulated in the Tgfbr2 mutant MEE. (A) Irf6 is e
detectable in the K14-Cre;Tgfbr2fl/fl mutant sample. (C)MMP13 is expressed in the w
the K14-Cre;Tgfbr2fl/fl mutant sample.submucous cleft palate phenotype. Thus, we show that Tgfbr2 is
specifically required for the disappearance of MEE.
The fate of medial edge epithelium
Most previous MEE tracking experiments were conducted
using in vitro labeling with lipophilic molecule carboxyfluo-
rescein. The fidelity of these labeling and tracking approaches
are always questionable. Taking advantage of the two-
component genetic system, we were able to mark indeliblyxpressed in the wild-type MEE during the palatal fusing process. (B) Irf6 is not
ild-type MEE during the palatal fusing process. (D)MMP13 is not detectable in
245X. Xu et al. / Developmental Biology 297 (2006) 238–248the MEE cells prior to palatal shelf contact and fusion in vivo.
K14 expression has been extensively described in the ectoderm
and its derivatives, and the K14 promoter element is widely
used to direct ectodermal transgene expression (Byrne et al.,
1994). Multiple K14-Cre transgenic mouse lines have been
generated by different laboratories (Andl et al., 2004; Dassule
et al., 2000; Indra et al., 2000; Jonkers et al., 2001; Vasioukhin
et al., 1999), but the activation time of theK14 promoter and the
expression level of CRE recombinase vary in these transgenic
lines. For example, in theK14-Cre line that we obtained from the
MMHCC [Mouse Model for Human Cancers Consortium]
(Jonkers et al., 2001), the K14 promoter was not fully functional
until postnatal 28 days (data not shown). Before this stage, the
CRE activity exhibited a mosaic expression pattern in the
ectodermal derived cells as examined by lac-Z staining [(Jonkers
et al., 2001) and data not shown]. This K14-Cre transgenic allele
may be ideal for certain oncogenesis studies but is not suitable
for the research of organogenesis that has almost completed
development at the time of birth. The K14-Cre transgenic mice
that we used in this study have a K14 promoter that is active as
early as E9.5 (data not shown). At E13.5, before palatal fusion
started, every single cell in the palatal shelf epithelium has a
robust expression of CRE recombinase, as demonstrated by lac-
Z staining. The expression pattern was specifically restricted to
epithelial cells, and there was no ectopic expression. By crossing
this K14-Cre mouse with R26R reporter allele, we were able to
label every cell in the MEE in vivo prior to palatal fusion, which
was not achieved in the recent study on the fate of MEE (Vaziri
Sani et al., 2005). In our study, we found that no lac-Z-positive
cells were ever detected in palatal mesenchyme at any stage of
palatal development, thus ruling out the possibility of epithelial–
mesenchymal transformation (EMT) during palatogenesis.
EMToccurs at multiple sites during embryonic development.
The formation of neural crest cells is a classic example of EMT,
in which ectodermally derived cells emigrate into mesenchyme
and contribute to the development of multiple organs (Chai et al.,
2003). The two-component genetic system has been success-
fully used previously to investigate the fate of neural crest cells,
demonstrating that this approach is extremely reliable and
reproducible in terms of documenting the process of EMT (Chai
et al., 2000; Jiang et al., 2000). It is well documented that MEE
cells undergo apoptosis or migrate away from the midline in
order to facilitate palate fusion (Carette and Ferguson, 1992;
Martinez-Alvarez et al., 2000). To date, there is not yet a study
that convincingly demonstrates the biological significance of
EMT during palatal fusion. Taken together, we conclude that
EMT is not one of mechanisms that are responsible for
eliminating MEE cells during palatogenesis.
The function of TGF-β IIR in MEE during palatogenesis
As one of the most common human birth defects, cleft
palate has been extensively studied. Multiple genes have been
found to play important roles in regulating palatogenesis.
Many cleft palate animal models have been developed in the
last decade, such as Msx1−/− (Satokata and Maas, 1994),
Tgfb3−/− (Kaartinen et al., 1995; Proetzel et al., 1995), Dlx2−/−(Qiu et al., 1997), Pax9−/− (Peters et al., 1998), Pitx1−/− (Szeto
et al., 1999), Lhx8−/− (Zhao et al., 1999). Interestingly, all of
these knockout mouse models exhibit a complete cleft through
the anterior to the posterior of the palate, a phenotype that only
represents part of the human cleft palate phenotype spectrum.
Many human cleft palate cases are soft palate cleft and
submucous cleft, which is defined by the classic triad: a bifid
uvula, palatal muscle diastasis, and a notch in the posterior
surface of the hard palate (Gosain et al., 1996). Until now, the
etiology of the soft palate cleft and submucous cleft has not
been well understood. Recently, heterozygous mutations in
TGFBR1 or TGFBR2 have been found to cause multiple human
congenital malformations, including cleft palate and/or bifid
uvula (Loeys et al., 2005). In our study, palatal defects in the
K14-Cre;Tgfbr2fl/fl mouse do, in fact, resemble the symptoms
of submucosal cleft palate and soft palate cleft. For the first
time, we provide an animal model for this type of human birth
defect.
Compared with Tgfb3 knockout mice, K14-Cre;Tgfbr2fl/fl
mice exhibit less severe defects in the palate. The secondary
palatal shelves were able to contact and adhere together at the
anterior part of the palate. On the other hand, most of the Tgfb3
null mutant mice suffer from a complete bilateral clefting of the
secondary palate (Fig. 2G) (Cui et al., 2005; Kaartinen et al.,
1997; Proetzel et al., 1995), and there was obvious tissue
shortage. When placed in close contact in vitro, cultured Tgfb3-
null palatal shelves fail to fuse, but become adherent (Kaartinen
et al., 1997). Obviously, TGF-β3, as a prototypical TGF-β
ligand, is not only required cell autonomously for the MEE, but
also serves as an important paracrine signal for the palatal
mesenchyme during palatogenesis. We have recently learned
that there was indeed a cell proliferation defect in the palatal
mesenchyme of Tgfb3−/− embryo (see Fig. 2J). In this study, we
disrupted TGF-β signaling pathway at the receptor level in a
tissue specific manner, and, therefore, the defects were restricted
to the epithelial-derived MEE. Furthermore, our previous study
has shown that the CNC-derived palatal mesenchyme has a cell
autonomous requirement for Tgfbr2 in regulating cell prolifer-
ation (Ito et al., 2003). Taken together, TGF-β IIR signaling has
distinctive roles in regulating the fate of the MEE and the CNC-
derived palatal mesenchyme during palatogenesis.
It has been previously shown that TGF-β can induce
apoptosis in epithelial cells (Sporn et al., 1987). Apoptosis is the
major fate of MEE during palatogenesis (Cuervo and
Covarrubias, 2004). Our data show that MEE cells deficient
in Tgfbr2 gene do not undergo cell death and retain the ability to
proliferate, therefore changing the fate of MEE. It appears that
TGF-β IIR is specifically required to regulate the fate of MEE in
a cell autonomous fashion.
It is interesting that K14-Cre;Tgfbr2 mutant mice showed a
complete and well defined failure of fusion anteriorly while
there was adhesion and epithelial cyst formation between
palatal shelves of the secondary hard palate, followed by wide
cleft in the soft palate. We evaluated cell proliferation and
apoptotic activities separately in anterior, middle and posterior
parts of the palate. We observed a lack of apoptosis and
persistent cell proliferation consistently in the MEE throughout
246 X. Xu et al. / Developmental Biology 297 (2006) 238–248the entire palate in the Tgfbr2 mutant sample (Fig. 4). Palatal
muscle diastasis and mis-orientation of muscle fibers appear to
be responsible for the severe cleft in the soft palate. In the
anterior part of the palate in the Tgfbr2 mutant, increased
epithelial cell proliferation resulted in the formation of an
epithelial stalk (see Figs. 3B and 4D), which has prevented the
adhesion between the primary and secondary palatal shelves.
Despite these variations in the degree of clefting, it is clear that
TGF-β signaling is required throughout the entire MEE.
Downstream targets of the TGF-β signaling cascade
Mutations in IRF6 cause Van der Woude syndrome, which is
the most common form of syndromic cleft lip and palate
(Kondo et al., 2002). Recently, studies have shown that
variation within IRF6 is responsible for 12% of the genetic
contribution to cleft lip and palate. The risk of recurrence is
three times higher in families that already have one affected
child (Zucchero et al., 2004). Irf6 is expressed in the ectoderm
of facial primordia during mouse embryonic development and
has an identical expression pattern to that of Tgfb3 in the MEE
prior to palatal fusion (Knight et al., 2006). As Irf6 is expressed
in both lip and palate ectoderm, it may account for the mixed
clefting phenotype (cleft lip with cleft palate) in Van der Woude
syndrome. Significantly, Irf6 expression is downregulated in the
MEE of the Tgfb3 null mutant (Knight et al., 2006). In this
study, we show that there was compromised Irf6 expression in
the MEE of Tgfbr2 mutant sample. Taken together, our study
suggests that TGF-β signaling mediated Irf6 expression is
critical for MEE cells to undergo apoptosis and to cease
proliferation during palatal fusion. Future studies using
transgenic mice to overexpress the Irf6 gene will allow us to
test whether this approach can rescue cleft palate defect in
Tgfb3−/− or K14-Cre;Tgfbr2fl/fl mutant mice.
The expression of Mmp13, a matrix metalloproteinase
strongly induced by TGF-β3 in MEE during palatogenesis
(Blavier et al., 2001), was also significantly reduced in the K14-
Cre;Tgfbr2fl/fl mice. Interestingly, in vivo collagenolytic
activity has been widely attributed to MMP13 activity in mice
(Hartenstein et al., 2006). The physiological expression of
MMP13 is limited to situations in which rapid and effective
remodeling of collagenous ECM is taking place (Blavier et al.,
2001). Palatal fusion is a complicated process that requires
ECM remodeling, and it is completed within a very short period
of time (Morris-Wiman et al., 1999). On the basis of our data
and previous studies, we propose that MMP13 is one of the
downstream targets of TGF-β signaling in the MEE and plays
an essential role in the palatal fusion process.
In summary, our study clearly shows that epithelial–
mesenchymal transformation does not occur in the process of
palatal fusion. TGF-β IIR plays a crucial, cell autonomous role
in regulating the fate of MEE during palatogenesis. Future
studies using this animal model will provide important
information on the molecular mechanism of TGF-β signaling
in regulating normal and abnormal palatogenesis. Genetic
screening of TGF-BR2 mutation among individuals with soft
palate cleft and submucous cleft may provide crucial informa-tion in linkage analysis to investigate the etiology of congenital
malformations.
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